Skip to main content
Erschienen in: Diabetologia 5/2004

01.05.2004 | For Debate

Beta cell function and its relation to insulin action in humans: a critical appraisal

verfasst von: E. Ferrannini, A. Mari

Erschienen in: Diabetologia | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Abstract

The importance of both insulin resistance and beta cell dysfunction in the pathogenesis of glucose intolerance is widely recognised. Also popular is the concept that beta cell secretory function must be viewed in the context of extant insulin resistance. This For Debate moves from the premise that, whilst insulin action in vivo can be measured directly by a variety of essentially coherent techniques, measurement of beta cell function is more problematic. We therefore concisely survey the principal in vivo techniques that explore the diverse aspects of beta cell function and conclude that: (i) inter-correlation of clinical tests is only modest in non-diabetic subjects and poor in diabetic individuals; (ii) no single clinical test allows beta cell function to be assessed with accuracy and specificity comparable to those of insulin sensitivity; and (iii) short of complex experiments, mathematical modelling is necessary to interpret insulin secretory responses. Next we discuss the hyperbola paradigm used to describe the reciprocal relation of beta cell function to insulin sensitivity and suggest that: (i) insulin responses reflecting the basal beta cell tone are indeed inversely related to insulin action across degrees of glucose intolerance; (ii) modes of beta cell function that selectively reflect the dynamic response to acutely changing glucose concentrations are largely independent of insulin action; and (iii) when measured by experiment or resolved by modelling, quantitatively the most important of these dynamic secretion parameters is the glucose dose-response curve (glucose sensitivity). In fact, glucose excursions following glucose ingestion (i.e. glucose tolerance) are best explained by dynamic parameters of beta cell function.
Literatur
1.
Zurück zum Zitat Morgan LM, Aspostolakou F, Wright J, Gama R (1999) Diurnal variations in peripheral insulin resistance and plasma non-esterified fatty acid concentrations: a possible link? Ann Clin Biochem 36:447–450PubMed Morgan LM, Aspostolakou F, Wright J, Gama R (1999) Diurnal variations in peripheral insulin resistance and plasma non-esterified fatty acid concentrations: a possible link? Ann Clin Biochem 36:447–450PubMed
2.
Zurück zum Zitat Ferrannini E (1998) Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 19:477–490PubMed Ferrannini E (1998) Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 19:477–490PubMed
3.
Zurück zum Zitat DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 273:E214–E223 DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 273:E214–E223
4.
5.
Zurück zum Zitat Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6:45–86PubMed Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6:45–86PubMed
6.
Zurück zum Zitat Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U (1996) Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 45:947–953PubMed Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U (1996) Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 45:947–953PubMed
7.
Zurück zum Zitat Haffner SM, Howard G, Mayer E et al. (1997) Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 46:63–69PubMed Haffner SM, Howard G, Mayer E et al. (1997) Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 46:63–69PubMed
8.
Zurück zum Zitat Clausen JO, Borch-Johnsen K, Ibsen H et al. (1996) Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. J Clin Invest 98:1195–1209PubMed Clausen JO, Borch-Johnsen K, Ibsen H et al. (1996) Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. J Clin Invest 98:1195–1209PubMed
9.
Zurück zum Zitat Camastra S, Bonora E, Del Prato S, Rett K, Weck M, Ferrannini E (1999) Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man. EGIR (European Group for the Study of Insulin Resistance). Int J Obes Relat Metab Disord 23:1307–1313CrossRefPubMed Camastra S, Bonora E, Del Prato S, Rett K, Weck M, Ferrannini E (1999) Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man. EGIR (European Group for the Study of Insulin Resistance). Int J Obes Relat Metab Disord 23:1307–1313CrossRefPubMed
10.
Zurück zum Zitat Howard BV, Mayer-Davis EJ, Goff D et al. (1998) Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Metabolism 47:1174–1179PubMed Howard BV, Mayer-Davis EJ, Goff D et al. (1998) Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Metabolism 47:1174–1179PubMed
11.
Zurück zum Zitat Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46:3–19 Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46:3–19
12.
Zurück zum Zitat McClenaghan NH, Flatt PR (1999) Physiological and pharmacological regulation of insulin release: insights offered through exploitation of insulin-secreting cell lines. Diabetes Obes Metab 1:137–150CrossRefPubMed McClenaghan NH, Flatt PR (1999) Physiological and pharmacological regulation of insulin release: insights offered through exploitation of insulin-secreting cell lines. Diabetes Obes Metab 1:137–150CrossRefPubMed
13.
Zurück zum Zitat Ferrannini E, Gastaldelli A, Miyazaki Y et al. (2003) Predominant role of reduced b-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 46:1211–1219CrossRefPubMed Ferrannini E, Gastaldelli A, Miyazaki Y et al. (2003) Predominant role of reduced b-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 46:1211–1219CrossRefPubMed
14.
Zurück zum Zitat Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA (2004) Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 47:31–39CrossRefPubMed Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA (2004) Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 47:31–39CrossRefPubMed
15.
Zurück zum Zitat Kahn SE, Porte D Jr (1997) The pathophysiology of type II (noninsulin-dependent) diabetes mellitus: implications for treatment. In: Porte D Jr, Sherwin RS (eds) Ellenberg and Rifkin’s diabetes mellitus: theory and practice, 5th edn. Appleton & Lange, Stamford, pp 487–512 Kahn SE, Porte D Jr (1997) The pathophysiology of type II (noninsulin-dependent) diabetes mellitus: implications for treatment. In: Porte D Jr, Sherwin RS (eds) Ellenberg and Rifkin’s diabetes mellitus: theory and practice, 5th edn. Appleton & Lange, Stamford, pp 487–512
16.
Zurück zum Zitat Robbins DC, Andersen L, Bowsher R et al. (1996) Report of the American Diabetes Association’s Task Force on standardization of the insulin assay. Diabetes 45:242–256PubMed Robbins DC, Andersen L, Bowsher R et al. (1996) Report of the American Diabetes Association’s Task Force on standardization of the insulin assay. Diabetes 45:242–256PubMed
17.
Zurück zum Zitat Ferrannini E, Cobelli C (1987) The kinetics of insulin in man. I. General aspects. Diab Metab Rev 3:335–363 Ferrannini E, Cobelli C (1987) The kinetics of insulin in man. I. General aspects. Diab Metab Rev 3:335–363
18.
Zurück zum Zitat Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G (1997) Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166–1173PubMed Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G (1997) Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166–1173PubMed
19.
Zurück zum Zitat Ferrannini E, Pilo A (1979) Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance. J Clin Invest 64:243–254PubMed Ferrannini E, Pilo A (1979) Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance. J Clin Invest 64:243–254PubMed
20.
Zurück zum Zitat Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J (1980) Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab 51:520–528 Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J (1980) Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab 51:520–528
21.
Zurück zum Zitat Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377PubMed Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377PubMed
22.
Zurück zum Zitat Mykkanen L, Zaccaro DJ, Hales CN, Festa A, Haffner SM (1999) The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study. Diabetologia 42:1060–1066 Mykkanen L, Zaccaro DJ, Hales CN, Festa A, Haffner SM (1999) The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study. Diabetologia 42:1060–1066
23.
Zurück zum Zitat Haffner SM, Gonzalez C, Mykkanen L, Stern M (1997) Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 40:830–837 Haffner SM, Gonzalez C, Mykkanen L, Stern M (1997) Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 40:830–837
24.
Zurück zum Zitat Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed
25.
Zurück zum Zitat Stumvoll M, Mitrakou A, Pimenta W et al. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295–301 Stumvoll M, Mitrakou A, Pimenta W et al. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295–301
26.
Zurück zum Zitat Toschi E, Camastra S, Sironi AM et al. (2002) Effect of acute hyperglycemia on insulin secretion in man. Diabetes 51 [Suppl 1]:S130–S133 Toschi E, Camastra S, Sironi AM et al. (2002) Effect of acute hyperglycemia on insulin secretion in man. Diabetes 51 [Suppl 1]:S130–S133
27.
Zurück zum Zitat DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J (1983) Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 32:35–45 DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J (1983) Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 32:35–45
28.
Zurück zum Zitat Polonsky KS (1995) Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research. Diabetes 44:705–717 Polonsky KS (1995) Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research. Diabetes 44:705–717
29.
Zurück zum Zitat Toffolo G, Breda E, Cavaghan MK, Ehrmann DA, Polonsky KS, Cobelli C (2001) Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models. Am J Physiol 280:E2–E10 Toffolo G, Breda E, Cavaghan MK, Ehrmann DA, Polonsky KS, Cobelli C (2001) Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models. Am J Physiol 280:E2–E10
30.
Zurück zum Zitat Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr (1984) Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74:1318–1328PubMed Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr (1984) Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74:1318–1328PubMed
31.
Zurück zum Zitat Mears D, Atwater I (2000) Electrophysiology of the pancreatic β-cell. In: LeRoith D, Taylor S, Olefsky J (eds) Diabetes mellitus. A fundamental and clinical text, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 47–61 Mears D, Atwater I (2000) Electrophysiology of the pancreatic β-cell. In: LeRoith D, Taylor S, Olefsky J (eds) Diabetes mellitus. A fundamental and clinical text, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 47–61
32.
Zurück zum Zitat Atwater I, Carroll P, Li M (1989) Electrophysiology of the pancreatic β-cell. In: Draznin B, Melmed S, LeRoith D (eds) Molecular and cellular biology of diabetes mellitus. Alan R. Liss, New York, p 49 Atwater I, Carroll P, Li M (1989) Electrophysiology of the pancreatic β-cell. In: Draznin B, Melmed S, LeRoith D (eds) Molecular and cellular biology of diabetes mellitus. Alan R. Liss, New York, p 49
33.
Zurück zum Zitat Grodsky GM (1972) A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling. J Clin Invest 51:2047–2059PubMed Grodsky GM (1972) A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling. J Clin Invest 51:2047–2059PubMed
34.
Zurück zum Zitat Wollheim CB, Sharp GW (1981) Regulation of insulin release by calcium. Physiol Rev 61:914–973PubMed Wollheim CB, Sharp GW (1981) Regulation of insulin release by calcium. Physiol Rev 61:914–973PubMed
35.
Zurück zum Zitat Bratanova-Tochkova TK, Cheng H, Daniel S et al. (2002) Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes 51 [Suppl 1]:S83–S90 Bratanova-Tochkova TK, Cheng H, Daniel S et al. (2002) Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes 51 [Suppl 1]:S83–S90
36.
Zurück zum Zitat Henquin JC, Ishiyama N, Nenquin M, Ravier MA, Jonas JC (2002) Signals and pools underlying biphasic insulin secretion. Diabetes 51 [Suppl 1]:S60–S67 Henquin JC, Ishiyama N, Nenquin M, Ravier MA, Jonas JC (2002) Signals and pools underlying biphasic insulin secretion. Diabetes 51 [Suppl 1]:S60–S67
37.
Zurück zum Zitat Vahl TP, Paty BW, Fuller BD, Prigeon RL, D’Alessio DA (2003) Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1-(9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. J Clin Endocrinol Metab 88:1772–1779CrossRefPubMed Vahl TP, Paty BW, Fuller BD, Prigeon RL, D’Alessio DA (2003) Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1-(9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. J Clin Endocrinol Metab 88:1772–1779CrossRefPubMed
38.
Zurück zum Zitat Jonkers FC, Henquin JC (2001) Measurements of cytoplasmic Ca2+ in islet cell clusters show that glucose rapidly recruits beta-cells and gradually increases the individual cell response. Diabetes 50:540–550PubMed Jonkers FC, Henquin JC (2001) Measurements of cytoplasmic Ca2+ in islet cell clusters show that glucose rapidly recruits beta-cells and gradually increases the individual cell response. Diabetes 50:540–550PubMed
39.
Zurück zum Zitat Nijpels G, Wal PS van der, Bouter LM, Heine RJ (1994) Comparison of three methods for the quantification of beta-cell function and insulin sensitivity. Diabetes Res Clin Pract 26:189–195PubMed Nijpels G, Wal PS van der, Bouter LM, Heine RJ (1994) Comparison of three methods for the quantification of beta-cell function and insulin sensitivity. Diabetes Res Clin Pract 26:189–195PubMed
40.
Zurück zum Zitat Warram JH, Sigal RJ, Martin BC, Krolewski AS, Soeldner JS (1996) Natural history of impaired glucose tolerance: follow-up at Joslin Clinic. Diabet Med 13:S40–S45CrossRefPubMed Warram JH, Sigal RJ, Martin BC, Krolewski AS, Soeldner JS (1996) Natural history of impaired glucose tolerance: follow-up at Joslin Clinic. Diabet Med 13:S40–S45CrossRefPubMed
41.
Zurück zum Zitat Porte D Jr (1996) Normal physiology and phenotypic characterization of beta-cell function in subjects at risk for non-insulin-dependent diabetes mellitus. Diabet Med 13:S25–S32 Porte D Jr (1996) Normal physiology and phenotypic characterization of beta-cell function in subjects at risk for non-insulin-dependent diabetes mellitus. Diabet Med 13:S25–S32
42.
Zurück zum Zitat Licko V (1973) Threshold secretory mechanism: a model of derivative element in biological control. Bull Math Biol 35:51–58PubMed Licko V (1973) Threshold secretory mechanism: a model of derivative element in biological control. Bull Math Biol 35:51–58PubMed
43.
Zurück zum Zitat Bergman RN, Urquhart J (1971) The pilot gland approach to the study of insulin secretory dynamics. Recent Prog Horm Res 27:583–605PubMed Bergman RN, Urquhart J (1971) The pilot gland approach to the study of insulin secretory dynamics. Recent Prog Horm Res 27:583–605PubMed
44.
Zurück zum Zitat Cerasi E, Fick G, Rudemo M (1974) A mathematical model for the glucose induced insulin release in man. Eur J Clin Invest 4:267–278PubMed Cerasi E, Fick G, Rudemo M (1974) A mathematical model for the glucose induced insulin release in man. Eur J Clin Invest 4:267–278PubMed
45.
Zurück zum Zitat Toffolo G, Bergman RN, Finegood DT, Bowden CR, Cobelli C (1980) Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes 29:979–990PubMed Toffolo G, Bergman RN, Finegood DT, Bowden CR, Cobelli C (1980) Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes 29:979–990PubMed
46.
Zurück zum Zitat Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C (2001) Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 50:150–158PubMed Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C (2001) Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 50:150–158PubMed
47.
Zurück zum Zitat Cretti A, Lehtovirta M, Bonora E et al. (2001) Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest 31:405–416PubMed Cretti A, Lehtovirta M, Bonora E et al. (2001) Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest 31:405–416PubMed
48.
Zurück zum Zitat Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for the assessment of b-cell function: modeling analysis in normal subjects. Am J Physiol 283:E1159–E1166PubMed Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for the assessment of b-cell function: modeling analysis in normal subjects. Am J Physiol 283:E1159–E1166PubMed
49.
Zurück zum Zitat Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51 [Suppl 1]:S221–S226 Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51 [Suppl 1]:S221–S226
50.
Zurück zum Zitat Mari A (2002) Mathematical modeling in glucose metabolism and insulin secretion. Curr Opin Clin Nutr Metab Care 5:495–501CrossRefPubMed Mari A (2002) Mathematical modeling in glucose metabolism and insulin secretion. Curr Opin Clin Nutr Metab Care 5:495–501CrossRefPubMed
51.
Zurück zum Zitat Nesher R, Cerasi E (1987) Biphasic insulin release as the expression of combined inhibitory and potentiating effects of glucose. Endocrinology 121:1017–1024PubMed Nesher R, Cerasi E (1987) Biphasic insulin release as the expression of combined inhibitory and potentiating effects of glucose. Endocrinology 121:1017–1024PubMed
52.
Zurück zum Zitat Cerasi E (1981) Differential actions of glucose on insulin release: re-evaluation of a mathematical model. In: Cobelli C, Bergman RN (eds) Carbohydrate metabolism. Quantitative physiology and mathematical modelling. Wiley, Chichester, pp 3–22 Cerasi E (1981) Differential actions of glucose on insulin release: re-evaluation of a mathematical model. In: Cobelli C, Bergman RN (eds) Carbohydrate metabolism. Quantitative physiology and mathematical modelling. Wiley, Chichester, pp 3–22
53.
Zurück zum Zitat Kahn SE, Prigeon RL, McCulloch DK et al. (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672PubMed Kahn SE, Prigeon RL, McCulloch DK et al. (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663–1672PubMed
54.
Zurück zum Zitat Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMed Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMed
55.
Zurück zum Zitat Stumvoll M, Tataranni PA, Stefan N, Vozarova B, Bogardus C (2003) Glucose allostasis. Diabetes 52:903–909PubMed Stumvoll M, Tataranni PA, Stefan N, Vozarova B, Bogardus C (2003) Glucose allostasis. Diabetes 52:903–909PubMed
56.
Zurück zum Zitat Byrne M, Sturis J, Cavaghan M, O’Meara N, Polonsky K (2000) Insulin secretion in humans. Physiologic regulation and alterations in disease states. In: LeRoith D, Taylor S, Olefsky J (eds) Diabetes mellitus. A fundamental and clinical text, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 105–114 Byrne M, Sturis J, Cavaghan M, O’Meara N, Polonsky K (2000) Insulin secretion in humans. Physiologic regulation and alterations in disease states. In: LeRoith D, Taylor S, Olefsky J (eds) Diabetes mellitus. A fundamental and clinical text, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 105–114
57.
Zurück zum Zitat Natali A, Gastaldelli A, Galvan AQ et al. (1998) Effects of acute alpha 2-blockade on insulin action and secretion in humans. Am J Physiol 274:E57–E64PubMed Natali A, Gastaldelli A, Galvan AQ et al. (1998) Effects of acute alpha 2-blockade on insulin action and secretion in humans. Am J Physiol 274:E57–E64PubMed
Metadaten
Titel
Beta cell function and its relation to insulin action in humans: a critical appraisal
verfasst von
E. Ferrannini
A. Mari
Publikationsdatum
01.05.2004
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 5/2004
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1381-z

Weitere Artikel der Ausgabe 5/2004

Diabetologia 5/2004 Zur Ausgabe

Authors’ Reply

Author’s Reply

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.